New webinars available on BOPA website

There are a series of new Webinars available on the BOPA website which were recorded at the recent London Pharmacy Oncology Education Evening.

The BOPA Bursary team gave an update from ASCO18 including some specific trials and their experiences of the scheme.

You can watch a webinar of the whole meeting or just the bits you are interested in:
KEYNOTE-042
TAILORx
PRODIGE-24
PERSEPHONE
Other ASCO scientific highlights
Experience of using social media to disseminate education digitally

The webinars can all be found here: http://bit.ly/BOPAwebinars

Don’t forget that we also broadcast the event live on Periscope and you can watch the replays here: http://bit.ly/BOPAPeriscope
Plus all the Twitter coverage can be found here: https://twitter.com/i/moments/1044195877890478081

We hope this provides some useful inspiration for revalidation CPD entries as we near the 31st October deadline!

Marcus (on behalf of the BOPA Bursary Scheme team)
[email protected]
@eRxPharmacist

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article